加州药房提供的大麻草本产品中四氢大麻酚含量与价格关联数据表:消费者/患者视角
加州药房大麻产品THC/CBD浓度与价格等属性数据表,用于分析THC含量与价格关联及消费者/患者风险。

基本信息
资源简介
加州药房提供的大麻草本产品中四氢大麻酚含量与价格关联数据表:消费者/患者视角
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 178.27 KB,主题涵盖 Delta-9 tetrahydrocannabinol、cannabidiol、drug policy、marijuana、medical marijuana,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.pdf》。配套论文《The pharmacokinetics, efficacy, and safety of a novel selective‐dose cannabis inhaler in patients with chronic pain: A randomized, double‐blinded, placebo‐controlled trial》发表于 European Journal of Pain(2020),DOI:10.1002/ejp.1605。源站首次发布:2022-06-17。
【数据内容】
源站原始描述:Background and AimsThe U.S. legal cannabis market is saturated with products containing high levels of tetrahydrocannabinol (THC), with no distinction between medical and recreational programs. This omnipresence of potent cannabis products seems to be driven by the recreational realm, where cannabis with the highest THC content is prized. This prevalence of highly potent cannabis is conveyed to medical programs, which places consumers (patients) at higher risk for over consumption and cannabis u…
【数据结构与技术规格】
文件数 1 个,合计 178.27 KB。Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Con.pdf:application/pdf,178.27 KB。数据集 DOI:10.3389/fpubh.2022.893009.s001。
【主题与分类】
源站学科分类:Aboriginal and Torres Strait Islander Health、Aged Health Care、Care for Disabled、Community Child Health、Environmental and Occupational Health and Safety、Epidemiology。主题标签:Delta-9 tetrahydrocannabinol、cannabidiol、drug policy、marijuana、medical marijuana、legalization、dispensaries、price。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Association_of_Tetrahydrocannabinol_Content_and_Price_in_Herbal_Cannabis_Products_Offered_by_Dispensaries_in_California_A_Purview_of_Consumers_Patients_pdf/20087630
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Dobbins, MaryBeth; Rakkar, Mannat; Cunnane, Katharine; Pennypacker, Sarah D.; Wagoner, Kimberly G.; Reboussin, Beth A.; et al. (2022). Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients…
【使用注意】
· 源站最后修改于 2023-06-03,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.pdf
- DOI:10.3389/fpubh.2022.893009.s001
- 发布日期:2022-06-17
- 文件数:1 个
- 文件总体积:178.27 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Association_of_Tetrahydrocannabinol_Content_and_Price_in_Herbal_Cannabis_Products_Offered_by_Dispensaries_in_California_A_Purview_of_Consumers_Patients_pdf/20087630
命令行下载
curl -L -o "Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Con.pdf" "https://ndownloader.figshare.com/files/35930192"
文件清单
Data_Sheet_1_Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Con.pdf(178.27 KB)
文件总体积 178.27 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Background and AimsThe U.S. legal cannabis market is saturated with products containing high levels of tetrahydrocannabinol (THC), with no distinction between medical and recreational programs. This omnipresence of potent cannabis products seems to be driven by the recreational realm, where cannabis with the highest THC content is prized. This prevalence of highly potent cannabis is conveyed to medical programs, which places consumers (patients) at higher risk for over consumption and cannabis use disorder. Thus, understanding what factors influence the market that patients face in medical cannabis programs could shed light on the risks of legal cannabis. The supply and demand dynamic of the US for-profit cannabis market could explain the current market composition; therefore, we postulate that a financial gain could influence the perpetuation of the prevalence of high THC products in legal cannabis dispensaries. We investigate whether THC content in popular cannabis products correlates with higher prices and assess whether some attributes (type of product, chemovars, or presence of cannabidiol (CBD) affect the association of THC with price.
MethodsWe focus on the world’'s largest cannabis market, California. We randomly selected dispensaries across the state, screened for a web presence and product menu, determined the most prevalent product type, and collected THC and CBD concentration, price, and other product attributes.
ResultsWe observed that herbal products were more common, they had THC concentrations greater than 10%, and THC concentrations positively correlated with price. This correlation existed in flower and preroll presentations, all chemovar, and independently of the level of CBD. CBD did not correlate with price; however, the presence of CBD diminished the THC and price correlation particularly in products with high THC (>15%).
ConclusionsOverall, highly potent herbal cannabis products (>15% THC) are the majority of products offered and more expensive regardless of product type or chemovar in California dispensaries, suggesting that a financial gain contributes to the current market composition. Efforts to limit the availability of highly potent T
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fpubh.2022.893009.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Association_of_Tetrahydrocannabinol_Content_and_Price_in_Herbal_Cannabis_Products_Offered_by_Dispensaries_in_California_A_Purview_of_Consumers_Patients_pdf/20087630)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




